NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Talam Biotech

Talam Biotech

Private
Groton, ConnecticutHealthcare & Life Scienceshttps://talam.com/

Last Round

Debt

Jun 9, 2022

Total Funding Raised

$4.98M

Company Overview

Talam Biotech is an agricultural biotechnology company that develops natural microbial solutions to reduce the uptake of heavy metals in crops to protect food safety and improve soil health.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Sustainable Materials

Business Model

B2B

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

heavy metal reductionmicrobial seed coatingfood safetyagtechagricultural microbialsag biologicalsnon-GMO microbesseed treatmentcrop bioremediationheavy metal contaminationarsenic reductioncadmium reductionmicrobe discoverysoil microbiome

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Talam Biotech Comps

Public and private peers based on sector, stage, and business model.

Talam Biotech comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Talam Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtJun 9, 2022
Series AApr 29, 2020
AcceleratorApr 1, 2017
View all Funding Rounds

Talam Biotech Investors

Notable investors and investment history

Talam Biotech investors
InvestorRounds
SVG Ventures|THRIVEAccelerator, Series A
Connecticut InnovationsDebt
Open PrairieDebt
Fulcrum Global CapitalDebt, Series A
Corteva CatalystDebt
Yield Lab EuropeSeries A
SVG VenturesAccelerator
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 2, 2026

    Monthly visitors grew 94% MoM, reaching 4.4K.

  • Jun 1, 2025

    Monthly visitors grew 77% MoM, reaching 2.3K.

View all signals

Talam Biotech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Talam Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Talam Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersGroton, Connecticut
Employee Range11
Year Founded2012
Last FundingJun 9, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.